UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 2549
FORM N-PX
Investment Company Act File Number: 811-22299
RENN Fund, Inc.
(Exact name of Registrant as specified in charter)
c/o Horizon Asset Management LLC
470 Park Avenue South
New York, New York
10016
(Address of Principal Executive Offices)
(Zip Code)
Russell G. Cleveland
11520 North Central Expressway, Suite 162
Dallas, Texas 75243
(Name and Address of Agent for Service)
Registrant’s telephone number: 646-495-7330
Date of Fiscal Year-End: 12/31/2016
Date of reporting period: 07/01/2016 – 06/30/2017
Form N-PX is to be used by a registered management investment company, other than a small business investment company registered on Form N-5 (239.24 and 274.5 of this chapter), to file reports with the Commission, not later than August 31 of each year, containing the registrant’s proxy voting record for the most recent twelve-month period ended June 30, pursuant to section 30 of the Investment Company Act of 1940 and rule 30b1-4 thereunder (17 CRR 270.30b1-4). The Commission may use the information provided on Form N-PX in its regulatory, disclosure review, inspection, and policymaking roles.
A registrant is required to disclose the information specified by Form N-PX, and the Commission will make this information public.
Item 1: Proxy Voting Record.
Disclosed is the following information for each matter relating to a portfolio security considered at any shareholder meeting held during the period covered by the report and with respect to which the registrant was entitled to vote:
Pursuant to the requirements of the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Registrant: | RENN Fund, Inc. |
By: | /s/ Russell Cleveland |
Title: | President, CEO, and Director |
Date: | August 31, 2017 |
Bovie Medical Corporation | |||
Ticker: | BVX | Security ID: | 10211F100 |
Meeting Date: | July 28, 2016 | Meeting Type: | Annual |
Record Date: | June 10, 2106 |
Item: | Matter to be Voted On: | Proposed by: | Shares Voted: | How Voted: | For or Against Management: |
1.0 | Elect eight directors to the Board of Directors of the Company to serve until the 2017 Annual Meeting of Stockholders | ||||
1.1 | Andrew Makrides | Management | Yes | For | For |
1.2 | Robert L. Gershon | Management | Yes | For | For |
1.3 | J. Robert Saron | Management | Yes | For | For |
1.4 | Charles T. Orsatti | Management | Yes | For | For |
1.5 | Michael Geraghty | Management | Yes | For | For |
1.6 | Lawrence J. Waldman | Management | Yes | For | For |
1.7 | John C. Andres | Management | Yes | For | For |
1.8 | Scott Davidson | Management | Yes | For | For |
2.0 | The ratification of Frazier & Deeter, LLC as the Company’s independent public accountants for the year ending December 31, 2016. | Management | Yes | For | For |
3.0 | The approval of a non-binding advisory resolution supporting the compensation of our named executive officers. | Management | Yes | For | For |
FitLife Brands |
|||
Ticker: | FTLF | Cusip #: | 33817P108 |
Meeting Date: | June 22, 2017 | Meeting Type: | Annual |
Record Date: | June 5, 2017 |
Item: | Matter to be Voted On: | Proposed by: | Shares Voted: | How Voted: | For or Against Management: |
1.0 | Esection of Directors: | Management | Yes | For | For |
1.1 | John S. Wilson | Management | Yes | For | For |
1.2 | Michael Abrams | Management | Yes | For | For |
1.3 | Lewis Jaffe | Management | Yes | For | For |
1.4 | Grant Dawson | Management | Yes | For | For |
1.5 | Seth Yakatan | Management | Yes | For | For |
1.6 | Todd Ordal | Management | Yes | For | For |
17 | Dayton Judd | Management | Yes | For | For |
2.0 | An Advisory Vote regarding the approval of compensation paid to our named executive officers | Management | Yes | For | For |
3.0 | Ratifying the appointment of Weinberg & Company P.A. as FitLife Brands, Inc.’s independent auditor for the fiscal year ending December 31, 2017. | Management | Yes | For | For |